Financing

Dividends Paid

Regeneron Pharmaceuticals Dividends Paid increased by 5.5% to $97.80M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 4.3%, from $93.80M to $97.80M. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementCash Flow Statement
SectionFinancing
CategoryCapital Allocation
SignalHigher is better
VolatilityStable
First reportedQ1 2023
Last reportedQ1 2026Apr 29, 2026

How to read this metric

Consistent or growing dividend payments signal financial stability and a mature, reliable business model.

Detailed definition

The total cash distributed to shareholders as a return on their investment. This metric is a key indicator of the compan...

Peer comparison

Highly comparable across blue-chip companies; dividend yield and payout ratios are standard peer benchmarks.

Metric ID: dividends_paid

Historical Data

13 periods
 Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$93.80M$92.60M$91.20M$92.70M$97.80M
QoQ Change-1.3%-1.5%+1.6%+5.5%
YoY Change+4.3%
Range$0.00$97.80M
Avg YoY Growth+4.3%
Median YoY Growth+4.3%
Current Streak2 quarters growth

Frequently Asked Questions

What is Regeneron Pharmaceuticals's dividends paid?
Regeneron Pharmaceuticals (REGN) reported dividends paid of $97.80M in Q1 2026.
How has Regeneron Pharmaceuticals's dividends paid changed year-over-year?
Regeneron Pharmaceuticals's dividends paid increased by 4.3% year-over-year, from $93.80M to $97.80M.
What does dividends paid mean?
Cash payments made to shareholders as dividends.